Announcement of termination of co-promotion of anti-depressant, Paxil CR Tablets
Posted Annual Report 2014
"Corporate profile" An English version and a Japanese version are updated.
Sunovion Pharmaceuticals Inc. to Divest Xopenex (levalbuterol HCI) Inhalation Solution (IS) to Akorn, Inc.
Sumitomo Dainippon Pharma Acquires Patent License from DNAVEC On Clinical-grade iPS Cell Production Technology
Sumitomo Dainippon Pharma and SanBio Conclude Joint Development and License Agreement for North America With Respect to SB623, a Therapy for Stroke
A Message from the President
Board of Directors and Executive Officers